Nic Tapon, a senior group leader at the Francis Crick Institute, has been elected as a member of the European Molecular Biology Organisation (EMBO) in recognition of his high quality life sciences research.
Becoming a member of EMBO gives scientists the opportunity to meet and collaborate with other molecular biologists in Europe.
Nic is one of 62 new members who will join more than 1,800 of the best researchers in Europe and around the world.
"EMBO is an amazing organisation that not only promotes scientific excellence and training, but also pushes boundaries in promoting diversity and outreach to the developing world," says Nic. "I feel hugely privileged to have been selected for membership and am looking forward to taking part in EMBO's important work."
As head of the Apoptosis and Proliferation Control Lab, Nic is interested in understanding how tissue size is specified during development and adulthood, and what happens then this process goes wrong and leads to cancer formation.
The lab's major focus is the Hippo signalling pathway, which is dysregulated in many cancer types.
Paul Nurse, Director of the Crick and Secretary General of EMBO, said: "Congratulations to Nic for being elected to EMBO for his leading developmental biology and cancer research. He is a first-class researcher and a great addition to the EMBO community."
EMBO Director Maria Leptin said: "EMBO Members are leading scientists working across all of the life sciences. They also strengthen the research community in Europe and beyond through their international collaborations and connections."
The new EMBO Members and Associate Members will be formally welcomed at the Members' Meeting in Heidelberg between 24 and 26 October 2018.
